LOS ANGELES--(BUSINESS WIRE)--Sept. 11, 2006--Cougar Biotechnology, Inc., a publicly held biotechnology company, today announced the appointment of Russell H. Ellison, M.D., MSc, to the Company's Board of Directors. Dr. Ellison is currently the Vice President of Clinical Development of Fibrogen, Inc., a privately held biotechnology-based drug discovery company using its expertise in the fields of tissue fibrosis, connective tissue growth factor (CTGF), and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for fibrotic disorders, diabetic complications, anemia, ischemic disease, cancer, and other areas of unmet medical need.
